IMV Inc. (IMV) - 5i Research

IMV Inc. (IMV $1.12)
- View IMV Profile
- View Questions on IMV

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

IMV Inc. (IMV $1.12)
- View IMV Profile
- View Questions on IMV

Q: Hi Team, IMV 3rd quarter 2020 results and clinical update is good ?and worth to gamble on this company ?
Thanks as always,
Tak

Read Answer Asked by Tak on November 16, 2020

IMV Inc. (IMV $1.12)
- View IMV Profile
- View Questions on IMV

Q: Is there a potentially worthwhile option in the Canadian market for a company that's working on a vaccine, even indirectly?

Read Answer Asked by Bashir on August 05, 2020

Regeneron Pharmaceuticals Inc. (REGN $785.51)
- $785.51 P/E (TTM): 18.33X Cap: $83.04B
- View REGN Profile
- View Questions on REGN
Pfizer Inc. (PFE $27.22)
- $27.22 P/E (TTM): 15.4X Cap: $154.76B
- View PFE Profile
- View Questions on PFE
IMV Inc. (IMV $1.12)
- View IMV Profile
- View Questions on IMV
Inovio Pharmaceuticals Inc. (INO $1.66)
- $1.66 Cap: $112M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $8.25)
- $8.25 P/E (TTM): 4.16X Cap: $1.34B
- View NVAX Profile
- View Questions on NVAX
Moderna Inc. (MRNA $41.01)
- $41.01 Cap: $16.02B
- View MRNA Profile
- View Questions on MRNA
BioNTech SE (BNTX $106.62)
- $106.62 Cap: $25.58B
- View BNTX Profile
- View Questions on BNTX

Q: Is there a Canadian company that you would recommend that possibly would benefit from a vaccine to overcome Covid 19, if not what U.S. or international company would you recommend? Thank You.

Read Answer Asked by Brian on July 14, 2020